HFA 2022 Archives - Medical Conferences

Home > Cardiology > HFA 2022

Heart Failure Association
21–24 May 2022

Featured articles

HFA 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

HFA 2022

13 June, 2022 21:56

Online First

HFpEF burden in patients with COVID-19 calls for action

Presented By

Ms Jieling Chen, Gaithersburg, USA

Conference

HFA 2022

25 May, 2022 14:12

Delayed initiation of novel GDMTs may wreak havoc on HF patients

Presented By

Dr Gianluigi Savarese, Karolinska University Hospital, Sweden

Trial

EVOLUTION-HF

Conference

HFA 2022

25 May, 2022 14:09

EMPULSE: empagliflozin delivers rapid and clinically meaningful decongestion

Presented By

Prof. Piotr Ponikowski, Medical University of Wroclaw, Poland

Trial

Phase 3, EMPULSE

Conference

HFA 2022

25 May, 2022 14:03

DAPA-VO2: Rapid effect of dapagliflozin on Peak VO2 in stable HFrEF

Presented By

Dr Julio Núñez, University of Valencia, Spain

Trial

DAPA-VO2

Conference

HFA 2022

25 May, 2022 14:00

FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

FIDELITY

Conference

HFA 2022

25 May, 2022 13:55

REBALANCE-HF: Encouraging results of GSN ablation in HFpEF

Presented By

Dr Marat Fudim, Duke Cardiology Clinic, USA

Trial

REBALANCE-HF

Conference

HFA 2022

24 May, 2022 11:21

Dapagliflozin performs consistently across LVEF in HF

Presented By

Dr Mikhail Kosiborod, St. Luke’s Hospital, USA

Trial

DEFINE-HF; PRESERVED-HF

Conference

HFA 2022

24 May, 2022 11:15

First non-adrenergic drug to show benefit on BP in pre-cardiogenic shock

Presented By

Prof. Marco Metra, University of Brescia, Italy

Trial

SEISMiC

Conference

HFA 2022

24 May, 2022 11:12

HELIOS-A: Vutrisiran meets exploratory endpoints

Presented By

Dr Pablo García-Pavía, Hospital Universitario Puerta de Hierro Majadahonda, Spain

Trial

Phase 3, HELIOS-A

Conference

HFA 2022

24 May, 2022 11:09

DAPA-HF: Dapagliflozin safe and efficacious in frail patients

Presented By

Dr Jawad Haider Butt, Copenhagen University Hospital, Denmark

Trial

DAPA-HF

Conference

HFA 2022

23 May, 2022 15:53

Cardiac contractility modulation therapy promising for patients with HFpEF

Presented By

Prof. Cecilia Linde, Karolinska University Hospital, Sweden

Trial

CCM-HFpEF

Conference

HFA 2022

23 May, 2022 15:50

EMPEROR-Preserved: Empagliflozin stable across age groups

Presented By

Prof. Michael Böhm, University of the Saarland, Germany

Trial

EMPEROR-Preserved

Conference

HFA 2022

23 May, 2022 15:45

Should ATTR-CM be added to differential diagnosis of patients with HF?

Presented By

Dr Rocío Ruiz Hueso, University Hospital of Virgen Macarena, Spain

Conference

HFA 2022

23 May, 2022 15:42

GALACTIC-HF: Omecamtiv mecarbil option for HFrEF patients with low SBP

Presented By

Prof. Marco Metra, University of Brescia, Italy

Trial

GALACTIC-HF

Conference

HFA 2022

23 May, 2022 15:39

Featured articles

CONTENTS

Online First